Caris Life Sciences Inc.
CAI | NASDAQ
$32.88
-$1.45 (-4.22%)
Nov 2, 2026, 10:56 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 263.71M | 216.17M | 292.89M | 216.83M | 181.4M | 120.92M | 129.91M | 101.62M | 100.05M | 80.68M | 100.83M | 85.7M | 80.8M |
Cost of Revenue | 84.12M | 74.83M | 71.97M | 69.33M | 67.71M | 63.85M | 59.21M | 57.21M | 62.5M | 54.56M | 46.74M | n/a | 42.21M |
Gross Profit | 179.6M | 141.35M | 220.91M | 147.51M | 113.69M | 57.06M | 70.7M | 44.41M | 37.55M | 26.11M | 54.09M | 85.7M | 38.59M |
Operating Income | 26.93M | 5.28M | 88.41M | 32.64M | 17.99M | -57.95M | -37.05M | -60.84M | 67.01M | -92.23M | 66.44M | 50.84M | 48.76M |
Interest Income | 6.82M | 6.83M | 7.02M | 7.36M | 1.62M | 503K | 970K | 1.74M | 2.64M | 1.77M | n/a | n/a | n/a |
Pretax Income | -614K | -644K | 81.96M | 24.33M | -71.79M | -102.58M | -36.95M | -67.73M | -66.19M | -111.03M | 54.83M | 39.8M | 37.18M |
Net Income | -637K | -510K | 81.96M | 24.33M | -71.79M | -102.58M | -36.95M | -67.73M | -66.19M | -111.03M | 51.16M | 37.94M | 35.74M |
Selling & General & Admin | 120.31M | 104.75M | 100.66M | 93.24M | 106.63M | 91.95M | 80.64M | 77.61M | 79.78M | 83.96M | 12.29M | 10.17M | 7.74M |
Research & Development | 32.36M | 5.37M | 31.85M | 21.62M | 25.05M | 23.07M | 27.11M | 27.64M | 24.79M | 34.38M | n/a | n/a | n/a |
Other Expenses | n/a | 25.94M | n/a | n/a | -35.98M | 1K | n/a | n/a | -134.02M | n/a | n/a | 24.69M | n/a |
Operating Expenses | 152.67M | 136.07M | 132.5M | 114.86M | 95.7M | 115.02M | 107.75M | 105.25M | -29.46M | 118.34M | 12.29M | 34.86M | 7.74M |
Interest Expense | 9.23M | 12.81M | 11.36M | 13.51M | 19.21M | 12.78M | 13.26M | 13.8M | 13.67M | 9.29M | n/a | 11.11M | 11.17M |
Selling & Marketing Expenses | 53.76M | 45.04M | 44.15M | 41.27M | 42.26M | 38.59M | n/a | 36.76M | 38.71M | 38.49M | n/a | n/a | n/a |
Cost & Expenses | 236.79M | 210.89M | 204.48M | 184.19M | 163.41M | 178.87M | 166.96M | 162.46M | 33.04M | 172.9M | 59.03M | 34.86M | 49.95M |
Income Tax Expense | 23K | -134K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.68M | 1.86M | 2.5M |
Shares Outstanding (Basic) | 282.89M | 282.56M | 282.33M | 282.1M | 268.44M | 254.79M | 281.09M | 281.09M | 254.79M | 254.79M | 17.34M | 17.28M | 17.27M |
Shares Outstanding (Diluted) | 282.89M | 282.56M | 289.89M | 297.21M | 276M | 254.79M | 281.09M | 281.09M | 254.79M | 254.79M | 17.53M | 17.48M | 17.52M |
EPS (Basic) | 0 | 0 | 0.29 | 0.09 | -1.93 | -0.40 | -0.22 | -0.33 | -0.35 | -0.53 | 2.95 | 2.07 | 2.07 |
EPS (Diluted) | 0 | 0 | 0.28 | 0.08 | -1.87 | -0.40 | -0.22 | -0.33 | -0.35 | -0.53 | 2.92 | 2.04 | 2.04 |
EBITDA | 15.15M | 17.23M | 97.6M | 42.7M | -46.17M | -82.75M | -27.98M | -50.31M | -40.9M | -84.03M | 87.72M | 50.91M | 77.12M |
EBIT | 8.61M | 12.17M | 93.31M | 37.83M | -52.58M | -89.8M | -37.05M | -60.84M | -52.51M | -101.74M | n/a | 50.91M | 48.35M |
Depreciation & Amortization | 6.54M | 5.07M | 4.29M | 4.87M | 6.41M | 7.05M | 9.07M | 10.53M | 11.61M | 17.71M | 32.88M | n/a | 28.77M |
Add to Watchlist
Select watchlists to add or remove CAI